elrexfio

Generic: elranatamab-bcmm

Labeler: u.s. pharmaceuticals
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name elrexfio
Generic Name elranatamab-bcmm
Labeler u.s. pharmaceuticals
Dosage Form INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients

elranatamab 44 mg/1.1mL

Manufacturer
U.S. Pharmaceuticals

Identifiers & Regulatory

Product NDC 63539-252
Product ID 63539-252_150555bf-e68c-4995-8166-7ce5a1af5900
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA761345
Listing Expiration 2027-12-31
Marketing Start 2023-08-15

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 63539252
Hyphenated Format 63539-252

Supplemental Identifiers

RxCUI
2644885 2644891
UNII
L0HR9A577V

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name elrexfio (source: ndc)
Generic Name elranatamab-bcmm (source: ndc)
Application Number BLA761345 (source: ndc)
Routes
SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 44 mg/1.1mL
source: ndc
Packaging
  • 1 VIAL, SINGLE-DOSE in 1 CARTON (63539-252-02) / 1.1 mL in 1 VIAL, SINGLE-DOSE (63539-252-01)
source: ndc

Packages (1)

Ingredients (1)

elranatamab (44 mg/1.1mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["SUBCUTANEOUS"], "spl_id": "150555bf-e68c-4995-8166-7ce5a1af5900", "openfda": {"unii": ["L0HR9A577V"], "rxcui": ["2644885", "2644891"], "spl_set_id": ["aa044060-5b4b-4692-bf0f-9a50e140b10e"], "manufacturer_name": ["U.S. Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (63539-252-02)  / 1.1 mL in 1 VIAL, SINGLE-DOSE (63539-252-01)", "package_ndc": "63539-252-02", "marketing_start_date": "20230815"}], "brand_name": "Elrexfio", "product_id": "63539-252_150555bf-e68c-4995-8166-7ce5a1af5900", "dosage_form": "INJECTION, SOLUTION", "product_ndc": "63539-252", "generic_name": "elranatamab-bcmm", "labeler_name": "U.S. Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Elrexfio", "active_ingredients": [{"name": "ELRANATAMAB", "strength": "44 mg/1.1mL"}], "application_number": "BLA761345", "marketing_category": "BLA", "marketing_start_date": "20230815", "listing_expiration_date": "20271231"}